chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 diagnosis in early February, symptoms resolved since then and he received his booster 3 days ago. Patient is a cancer patient, no recent chemo TX - patient had spleen removed approx. 4 months ago - had several vaccines three days ago (one COVID-19 booster) and has been running a fever, having N/V x 2 days.
Within few minutes of MMR shot, complete facial hives and hives on upper arm around the injection site.  Slight slur in speech from slight swelling in mouth.
Metallic smell. Started about 10 minutes after vaccine administration and occurred intermittently for about 30 seconds at a time every 10 minutes for almost an hour.  Adverse effect subsided after about an hour.
pt recv vax;early eve was itching;devel fever of 40C;apap given;arm became swollen & hard & painful;applied warm water w/ salt;induration of 50 mm & purplish red swelling in the ctr;area felt warm to touch;to MD;
Dose 1:a red rash with pain; Dose 1:  stiffness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Dose 1:a red rash with pain) and MUSCULOSKELETAL STIFFNESS (Dose 1:  stiffness at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced RASH (Dose 1:a red rash with pain) and MUSCULOSKELETAL STIFFNESS (Dose 1:  stiffness at the injection site). At the time of the report, RASH (Dose 1:a red rash with pain) and MUSCULOSKELETAL STIFFNESS (Dose 1:  stiffness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On 01/22/2021 in the morning, he was feeling really achy with a sore arm. That lasted for 3 days 01/25/2021. On 01/30/2021 he had a regular check to see his doctor, referred to a Hematologist /Oncologist. 02/01/2021- He went to see the Hematologist. 02/26/2021- He was diagnosed with MDS (Myelodysplastic Syndrome).
This report from study was reported via Pregnancy Registry (initial receipt 24-Apr-2014), concerns a neonate patient. The patient received concomitant medications in-utero from the mother. The mother's concomitant medications included prenatal vitamins (commenced in 2009), folic acid, calcium citrate, magnesium, ergocalciferol, omega 3 fatty acids, herbal remedies (for "ATW"), etanercept (for rheumatoid arthritis started in 2009), prednisone (for rheumatoid arthritis), methylprednisolone (for rheumatoid arthritis), progesterone (for in-vitro fertilization), estradiol valerate (for in-vitro fertilization), estradiol (for in-vitro fertilization), leuprorelin acetate (for in-vitro fertilization), TYLENOL (for rheumatoid arthritis pain), TUMS (for heartburns), azithromycin (for cough/cold), ibuprofen (for pain), baby acetylsalicyclic acid (for in-vitro fertilization protocol), omeprazole (for acid reflux), glibenclamide (for gestational diabetes), infliximab (for rheumatoid arthritis), iron (for anemia), DTaP (for babies' lungs). The patient's mother had a medical history of anemia (diagnosed in 2003), rheumatoid arthritis (diagnosed in 1989), infertility with diminished ovarian function (diagnosed in 2010), fevers (on 01-Aug-2013 and two times from 15-Sep-2013 to 01-Nov-2013), respiratory infections (15-Sep-2013 to 01-Nov-2013), heartburns, gestational diabetes and ovarian cysts (diagnosed in 2000). The estimated date of conception was 10-Jul-2013 and estimated date of delivery was 02-Apr-2014. The mother underwent ultrasounds on 13-Aug-2013, 18-Sep-2013, 06-Sep-2013 (which showed subchorionic hematoma), 21-Oct-2013, 05-Nov-2013 (which showed possible club foot in one twin), 31-Jan-2014 and 05-Mar-2014 and also underwent first trimester serum screen on 18-Sep-2013 and alfa-fetoprotein test on 05-Nov-2013. She also underwent non-stress/stress test on 10-Jan-2014 and 05-Feb-2014. On 24-Oct-2013, the patient received AFLURIA vaccine (batch number not provided) from the mother in-utero who received the 1 shot 1 day dose of AFLURIA. On 05-Mar-2014, the mother gave birth to twins at a gestational age of 36 weeks. Twin A was healthy without malformation while twin B (also the patient) was born with congenital anomaly. The patient's weight at the time of birth was 1816 grams with Apgars at 1 min and 5 mins as 9. On 05-Mar-2014, the patient was diagnosed with a ventricular septal defect. The medical record confirmation was pending. Outcome was not reported.
This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 55-year-old female patient who received SHINGRIX for prophylaxis. On 14th September 2018, the patient received the 1st dose of SHINGRIX. On 14th September 2018, 4 hrs after receiving SHINGRIX, the patient experienced tiredness and injection site pain. In September 2018, the patient experienced influenza-like symptoms, fever and bone pain. On 16th September 2018, the outcome of the tiredness, influenza-like symptoms, fever, injection site pain and bone pain were recovered/resolved. It was unknown if the reporter considered the tiredness, influenza-like symptoms, fever, injection site pain and bone pain to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on the left arm on Friday at around noon. On the same day, starting at around 4 PM, the patient experienced tiredness, pain at the injection site. Overnight (15th September 2018), she started to experience deep bone pain, fever and felt like she had the flu. The patient stated that by Sunday morning she was back to normal.
Pain in the arm; Nausea; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the arm), NAUSEA (Nausea) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the arm), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PAIN (Pain in the arm), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported.  No Treatment medication was reported.
Developed Bell's Palsy on L face on 4/23/21. Presented to me for evaluation on 4/27/21 since symptoms had not improved.
Nausea, large red itchy welt at injection site, body aches, chills, headache
Patient told provider he feet, legs, and hips hurt so bad that he could not get out of bed to eat of drink.
8 days after SECOND dose of moderna vaccine for covid, my husband broke out in a rash. He does have eczema in the cold winter months which we treat with over the counter lotions. At first, he thought the rash was due to the lotion we used because it started shortly after application of the lotion. (However, he has never had a reaction to lotions before over many years of using different brands and formulas). His skin was burning and itching throughout the day. By the time he returned from work, he had raised bumps over his back, upper arms, legs, buttocks, chest and forehead. He found some relief after a shower and use of an anti-flammatory cream (although his skin was still covered in the rash). By the time he woke next morning, it was gone.
Received smallpox vaccine 2/25 on LD. On 3/6 developed a rash on Right upper arm, at injection site and on her back. Rash is several clusters of erythema  papule, pustule lesions. Had some muscle aches and cills at that time also. No temp. taken. On 3/12 went to Dr. new lesions were still coming. The follow up states virology reports were negative. Pt's condition is still under investigation by a dermatologist.
Moderately pruritic rash, primarily located to upper extremities and over the left leg.
Breakthrough Case: I started to have a cough and a sore throat. I thought it was allergies. The next morning I had much more coughing which was continuous and painful. 05/09/2022 I decided to go to see my doctor and test for COVID-19 because I need to go out of town and my test came back positive. I was started on PAXLOVID. I started to feel better over the next few days. I did still have a cough and I was experiencing a funny taste in my mouth. A week later I tested for COVID-19 again and it came back negative. After about 3-4 days the symptoms returned. The cough had subsided. I did have a MOHS surgery which went well. I did experience fatigue and the cough came back more. On 05/21/2022 I took another COVID-19 test and it came back positive. I talked to my doctor and was told I could take cough medicine.
Pt experienced a local reaction on left deltoid (2x4 cm). Pt came into clinic with a temperature of 101.5.
In 2019 I started having symptoms. It started with my left hand and moved all the way up my arm, into my shoulder and into my neck.   They greatly escalated and greatly expanded after the vaccine. The symptoms went from under control to a raging wildfire. I noticed this when I could not work with my left arm. I began to experience general loss of coordination. If I had known that they were associated with dystonia, I don't know if I would have done the shot. I did work in public contact. I just think the vaccine should continue to be studied. The two may be unrelated, I just think it's an odd coincidence that they occurred at the same time. I was diagnosed with Dystonia in January or February in 2023. It's been a long history before I was finally diagnosed with Dystonia.
I had dose one of Shingrix one week ago. I have had two mild genital outbreaks in new areas on my penis. I had injection site pain for 2 days. I was fatigued and had headaches for 2 days. I had a bout of fatigue 5 days after the shot so severe I almost passed out while walking. I had another outbreak on penis 6 days after the vaccine. I was only having an outbreak about 1 time yearly prior to the vaccine. I?ve had HSV2 since 1984. I believe the outbreaks are most certainly related to the vaccine. I will probably pass on dose two.
This spontaneous report as received from a Nurse Practitioner refers to an unknown number of patients were inadvertently vaccinated with GARDASIL, RECOMBIVAX HB, VAQTA, and PEDVAXHIB had been improperly stored. No further information was provided. Additional information was received from Nurse practitioner, who reported that GARDASIL, RECOMBIVAXHIB, VAQTA, and PEDVAXHIB went through multiple unsupported temperature excursions from 10/09/2013 to 10/17/2013. The Nurse practitioner reported that PEDVAXHIB Lot# J005670, expiration 12/17/2015 was administered to 1 unspecified patient on 10/15/2013 (MARRS# 1401USA000275), 1 unspecified patient on 10/25/2013 (MARRS# 1401USA000276) and 1 unspecified patient on 10/29/2013. The Nurse practitioner also reported GARDASIL (Lot# J003727, expiration date 11/07/2015) was administered to 2 unspecified patients on 10/10/13 (MARRS# 1310USA015162), 2 unspecified patients on 10/12/13 (MARRS # 1401USA000269), 1 unspecified patient on 10/14/13 (MARRS# 1410USA000273), 1 unspecified patient on 10/17/13 (MARRS#1401USA000271) and 1 unspecified patient on 10/19/13 (MARRS# 1401USA000272). GARDASIL (Lot# J008423, expiration date 01/21/2016) was administered to 3 unspecified patients on 10/25/13 (MARRS# 1401USA000268) and 1 unspecified patient on 10/26/13 (MARRS# 1401USA00027). VAQTA (Lot# J008090, expiration date 08/23/2015) was administered to 1 unspecified patient on 10/17/2013 (MARRS# 1401USA000279) and 1 unspecified patient on 0/25/2013. RECOMBIVAX (Lot# H012250, expiration date 02/06/2015) was administered to 1 unspecified patient on 10/26/2013 (MARRS# 1401USA000277). No adverse effects reported. No further information was provided. Additional information has been requested.
Right upper arm with redness and swelling. Hot to touch. Treatment instructed to use cold compresses and give Tylenol as needed for pain.
Achey joints; nausea; vomiting; diarrhea; headache; Face swelling; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6199) via an unspecified route of administration in the left arm on 13May2021 at 17:00(at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included iron deficiency anemia, blood pressure high, sulfonamide allergy and allergy to walnuts, almonds, horse products. Concomitant medications included chlortalidone (CHLORTHALIDONE) and cetirizine hydrochloride (ZYRTEC); both for an unknown indication from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number:ER8737) via an unspecified route of administration in the arm left on 23Apr2021 at 09:45(at the age of 41-year-old) as a single dose for COVID-19 immunisation and took Percocet and Darvocet on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 21:00, within 4 hours of Shot, the patient experienced Face swelling. On 13May2021 at 23:00, 6 hours, the patient experienced nausea, vomiting, diarrhea, headache. On 14May2021, within 10-12 hours. the patient experienced Achey joints. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the face swelling, nausea, vomiting, diarrhea, headache and ache joints were ongoing.  No follow-up attempts are needed. No further information is expected.
Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles; Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles; Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles; Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles), CHILLS (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles), NAUSEA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles) and MYALGIA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Allergy to honey).    On 20-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form once. On 20-Jun-2021, the patient experienced PYREXIA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles), CHILLS (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles), NAUSEA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles) and MYALGIA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles). The patient was treated with PARACETAMOL for Adverse event, at an unspecified dose and frequency. On 21-Jun-2021, PYREXIA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles), CHILLS (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles), NAUSEA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles) and MYALGIA (Temperature 39,3 for 25 hours, severe chills, nausea, severe pain in muscles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.   Treatment included Paracetamol.
Ear swelling, hives on face and neck, facial tingling, rash on cheeks, tingling and itchiness in throat and face - 45-60 minutes after injection. Waiting for 30 minutes and no adverse effects until leaving facility
Pt with seizures and encephalitis 10 days after 2nd COVID vaccine.  No source of encephalitis was found, although workup continues.  Pt is recovering but still has extreme fatigue and decreased functioning including decreased mental stamina.
This spontaneous report was received from a consumer (patient's mother) refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant therapy was unknown. On 15-NOV-2017 the patient was vaccinated with expired VAQTA intramuscular injection (dose, units and frequency were unknown) (lot # N003194 and expiration date 28-OCT-2017). No adverse effects were reported. There was no product quality compliant reported.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65-year-old female patient received BNT162b2 (BNT162B2), on 12Jul2022 as dose 4 (booster), single (Lot number: FJ6963) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (ongoing), notes: Verbatim: Hypertension. Concomitant medication(s) included: ENALAPRIL taken for hypertension. Vaccination history included: covid-19 vaccine (Dose 1, Lot no. ERZ613), administration date: 23Mar2021, when the patient was 63-year-old, for Covid-19 immunization; BNT162b2 (Dose 2, Lot no. EW0158), administration date: 16Apr2021, when the patient was 63-year-old, for Covid-19 immunization, reaction(s): "patient have been having muscle pain; patient was having muscle pain", "they made her sick"; BNT162b2 (Dose 3, Lot no. EE2590), administration date: 22Oct2021, when the patient was 64-year-old, for Covid-19 immunization, reaction(s): "patient have been having muscle pain; patient was having muscle pain", "they made her sick". The following information was reported: MYALGIA (non-serious), outcome "not recovered", described as "patient have been having muscle pain"; ILLNESS (non-serious), outcome "unknown", described as "They made her sick"; MUSCLE SPASMS (non-serious), outcome "unknown", described as "muscle spasm". The events "patient have been having muscle pain", "they made her sick" and "muscle spasm" required emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of myalgia, muscle spasms. Additional information: Patient had not any prior vaccinations. It was reported that, consumer stated patient have been having muscle pain and she took the two vaccination Pfizer vaccination (Confirmed as Pfizer Covid19 vaccine) and she was reading where they said it cause muscle pain so she was calling in. Reporter stated, "23Mar2021, patient took the first one and the fourth month 16 2021(Confirmed as 16Apr2021) and then 22Oct2021 and then 12Jul2022 and patient was having muscle pain since Jun2021." Patient started experiencing her muscle pain around her birthday. She wanted to report it that she was having muscle pain because on the paper that she got it said one of the side effects was muscle pain." Treatment: Consumer stated she went to the Emergency room and then they kept her and they sent her to another hospital of what they saying. They gave her something for muscle spasm but they made her sick (Event captured conservatively) and she ended back in Emergency room. They made her sick and she was supposed to take them."
slept all day; very tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (slept all day) and FATIGUE (very tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and unknown) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy (The patient has received chemotherapy with her last chemotherapy treatment in July.).   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced SOMNOLENCE (slept all day) and FATIGUE (very tired). At the time of the report, SOMNOLENCE (slept all day) and FATIGUE (very tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.    No treatment information was provided.
Redness on skin in areas including the front of the neck, across the collar bone, and across the upper chest.  Area is very itchy and slightly bumpy. Not blotchy but all of area is red. Using Benadryl cream on skin and taking Benadryl tablets. As of 9/19/2022 at 8:53 pm there has not been improvement.
The clinic was giving Pfizer 3rd doses.  This patient accidently received a Pfizer 3rd dose but had received Moderna for her 1st and 2nd doses.  Patient is feeling feverish (a typical side effect of getting a booster vaccine).  No other issues reported.
I didn't have any symptoms other than a sore arm for the first day or two.  On Monday, my left arm started to hurt in a different way.  When I push on it, it is not sore anymore.  Now, when I try to lift my left arm, even a little bit, I have quite a bit of pain internally, in  my upper arm/ shoulder. I feel as though this is not from the actual vaccination, but possibly from how it was administered into my shoulder.  I do realize this is only day 3, but it has gotten worse from yesterday to today.
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a physician regarding a 22-year-old male patient who experienced cough, nausea, diarrhea and an uncomfortable feeling in his legs, from his hips down to his toes. At 22 years of age, the patient received a dose on 12-Dec-2003. Medical History: The patient had no relevant medical history. Product Details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 12-Dec-2003, at a pharmacy. Dose regimen was 0.5 mL (intranasal). Concomitant Therapy: Patient was not taking concomitant therapy. Event Details: On 13-Dec-2003, 1 day post immunization, the patient developed a cough. The next day he experienced nausea and diarrhea. On 15-Dec-2003, he developed "this sensation from his hips down to his toes". The patient explains it as "an uncomfortable feeling; he is not comfortable standing, sitting or walking." He feels "as if he has to change his position to get comfortable, but can not". He presented to an urgent care facility with this chief complaint, while traveling. No additional information was available at the time of this report.
patient reported arm pain from injection site that has not gone away since recieving on the shot on 2.26
Pt was given MMR, Varicella, and Hep A vaccines.  Eight days later he had a fever for 2 days, then mom noticed a red bumpy rash on his face.  The rash spread to body the following day.  He was seen in clinic on the 3rd day of rash.